Multiple Myeloma: What to Know

The oral medication causes more GI because it goes through the GI tract to be absorbed. Monoclonal antibodies are very important and have been mainstay of myeloma therapy in the last few years. Other novel ish therapies are sulline next door which is an oral selective inhibitor of nuclear export and leads to G.I toxicity and site of pina's. And then the gland to map Mafodotin which is a humanized antibody drug conjugate against B cell maturation antigen or BCMA, expressed on myeloma cells.